2022年郑州市肿瘤登记地区肺癌流行特征及2016—2022年变化趋势分析
Epidemiological Characteristics of Lung Cancer in Zhengzhou Cancer Registration Areas in 2022 and the trends from 2016 to 2022
投稿时间:2025-12-18  修订日期:2026-04-07
DOI:
中文关键词:  肺癌  发病率  死亡率  趋势分析  郑州
英文关键词:lung cancer  incidence  mortality  trend analysis  Zhengzhou
基金项目:
作者单位邮编
闫瑞平 郑州市疾病预防控制中心(郑州市卫生监督所) 450007
李建彬 郑州市疾病预防控制中心(郑州市卫生监督所) 450007
安戈 郑州市疾病预防控制中心(郑州市卫生监督所) 450007
郭向娇 郑州市疾病预防控制中心(郑州市卫生监督所) 450007
黄婼璇 郑州市疾病预防控制中心(郑州市卫生监督所) 450007
宋彩娟* 郑州市疾病预防控制中心(郑州市卫生监督所) 450007
摘要点击次数: 33
全文下载次数: 0
中文摘要:
      [目的]分析郑州市肿瘤登记地区2022年肺癌发病与死亡情况及其2016—2022年变化趋势,为郑州市制定肺癌防治策略提供依据。[方法]收集郑州市各肿瘤登记处上报质量合格的肺癌发病与死亡病例资料,计算粗发病率、粗死亡率、标化发病率、标化死亡率、0~74 岁累积发病率和 0~74 岁累积死亡率。采用平均年度变化百分比(AAPC)分析2016—2022年郑州市不同性别、年龄和城乡肺癌发病率和死亡率的变化趋势。[结果]2022年郑州市肺癌粗发病率为57.54/10万、中标发病率为36.57/10万、世标发病率为36.09/10万,肺癌发病数占全部恶性肿瘤新发病例的20.15%;粗死亡率为38.70/10万、中标死亡率为22.53/10万、和世标死亡率为22.43/10万,肺癌死亡数占全部恶性肿瘤死亡总数的26.62%。2022年郑州市男性肺癌发病率与死亡率均高于女性。年龄别发病率及死亡率均在45岁后呈现快速上升趋势,并于80~84岁年龄组达到峰值。2016—2022年,郑州市肺癌粗发病率与中标发病率整体呈缓慢上升态势,其中女性中标发病率上升趋势尤为显著,男性中标发病率无明显波动;郑州市肺癌粗死亡率呈上升趋势,而中标死亡率趋势平稳,其中城市地区中标死亡率呈下降趋势,农村地区中标死亡率无明显波动。[结论]2016—2022年郑州市肺癌中标发病率呈缓慢上升趋势,中标死亡率未见明显改变。男性及老年人是郑州市肺癌发病与死亡主要人群,但女性与中老年人群发病上升趋势较为突出,应予以重点关注,并深入探究其上升原因,后续应继续加强肺癌防控和筛查与早诊早治工作。
英文摘要:
      [Objective] To investigate the incidence and mortality of lung cancer in Zhengzhou in 2022 and the trends from 2016 to 2022 based on cancer registration data,so as to provide evidence for lung cancer prevention and treatment strategies.[Methods]Data on incidence and mortality of lung cancer with qualified registration quality were collected from cancer registration offices in Zhengzhou City,Crude incidence,crude mortality,age-standardized rates by Chinese standard population (ASIRC,ASMRC)and world standard population (ASIRW,ASMRW), 0~74 years old cumulative incidence and mortality rates in Zhengzhou in 2022 were calculated. The average annual percentage change (AAPC) was used to analyze the trends in the incidence and mortality of lung cancer in Zhengzhou City from 2016 to 2022 across different gender, age, and urban-rural area. [Results] The crude incidence rate of lung cancer in 2022 was 57.54/105, with an ASIRC of 36.57/105, and ASIRW of 36.09/105. Lung cancer accounted for 20.15% of all newly diagnosed cancer cases. the crude mortality rate was 38.70/105, with an ASMRC of 22.53/105, and ASMRW of 22.43/105, Lung cancer accounted for 26.62% of all deaths from cancers. In 2022, the incidence and mortality of men in Zhengzhou were higher than those of women.Age-specific incidence and mortality rates attributable to lung cancer demonstrated a steep upward trend following the age of 45 years and peaked in the 80–84 years age group. From 2016 to 2022, the crude incidence rate and ASIRC of lung cancer in Zhengzhou exhibited a slow upward trend. Specifically, the ASIRC in females increased significantly, while that in males showed no obvious fluctuation. The crude mortality rate presented an upward trend, whereas ASMRC showed a stable trend—among which the ASMRC in urban areas displayed a downward trend, while that in rural areas had no significant variation. [Conclusion] From 2016 to 2022, the incidence of lung cancer in Zhengzhou showed a slow upward trend, while the mortality rate of lung cancer showed a stable trend. Lung cancer mainly occurs in male and the elderly, but the incidences of lung cancer in female and the middle-aged and elderly population are rising rapidly, which needs to be paid attention to and actively explored. It should be continued to strengthen prevention,screening,early diagnosis, and treatment.
在线阅读     查看/发表评论  下载PDF阅读器